Table 2 Priority areas
More definitive, prospective, human clinical studies to define the links between the inflammatory process of COPD and cardiovascular disease/lung cancer | |
The development of experimental/animal models to define how the inflammation in COPD increases the risk of cardiovascular disease/lung cancer | |
The development of targeted antiinflammatory therapies in COPD to reduce the associated cardiovascular disease/lung cancer |